Portfolio Holdings Detail for ISIN IE00BHZPJ239

Stock Name / Fund	iShares MSCI EM ESG Enhanced UCITS ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	EDG2(GBP) LSE
ETF Ticker	EDG2.LS(GBP) CXE
ETF Ticker	EDM2.DE(EUR) CXE
ETF Ticker	EDM2z(USD) CXE
ETF Ticker	EMEG.MI(EUR) CXE
ETF Ticker	EMEG(EUR) ETF Plus
ETF Ticker	EDG2.L(GBP) LSE

Holdings detail for LEGN

Show aggregate LEGN holdings

News associated with LEGN

Brokerages Set Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Price Target at $74.22

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eleven ratings firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average 12 month price […] - 2025-09-19 02:43:01

Legend Biotech Becomes Oversold (LEGN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me - 2025-09-10 14:53:11

JPMorgan Chase & Co. Increases Legend Biotech (NASDAQ:LEGN) Price Target to $78.00

Legend Biotech (NASDAQ:LEGN – Get Free Report) had its price target raised by research analysts at JPMorgan Chase & Co. from $77.00 to $78.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of […] - 2025-08-27 02:30:45

Legend Biotech Breaks Below 200-Day Moving Average - Notable for LEGN

In trading on Monday, shares of Legend Biotech Corp (Symbol: LEGN) crossed below their 200 day moving average of $36.28, changing hands as low as $35.23 per share. Legend Biotech Corp shares are currently trading off about 2.5% on the day. The chart below shows the one year pe - 2025-08-11 12:46:01

Legend Biotech (NASDAQ:LEGN) Rating Increased to Strong-Buy at Cantor Fitzgerald

Legend Biotech (NASDAQ:LEGN – Get Free Report) was upgraded by analysts at Cantor Fitzgerald to a “strong-buy” rating in a note issued to investors on Monday,Zacks.com reports. Other equities research analysts also recently issued research reports about the company. Johnson Rice reissued a “buy” rating on shares of Legend Biotech in a research report on […] - 2025-08-06 03:12:50

GAMMA Investing LLC Boosts Position in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN)

GAMMA Investing LLC increased its holdings in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Free Report) by 145.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,291 shares of the company’s stock after purchasing an additional 765 […] - 2025-07-11 04:12:51

Legend Biotech (NASDAQ:LEGN) Receives Buy Rating from HC Wainwright

Legend Biotech (NASDAQ:LEGN – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They currently have a $75.00 price target on the stock. HC Wainwright’s price objective indicates a potential upside of 90.07% from the company’s previous close. A number of other […] - 2025-07-10 04:01:26

Rhumbline Advisers Purchases 391 Shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN)

Rhumbline Advisers lifted its position in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Free Report) by 1.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 28,029 shares of the company’s stock after acquiring an additional 391 shares during the quarter. Rhumbline Advisers’ holdings […] - 2025-06-20 04:25:11

Thursday's ETF with Unusual Volume: FTQI

The First Trust Nasdaq BuyWrite Income ETF is seeing unusually high volume in afternoon trading Thursday, with over 909,000 shares traded versus three month average volume of about 226,000. Shares of FTQI were down about 0.2% on the day. Components of that ETF with the highest - 2025-06-12 15:09:39

Tuesday's ETF with Unusual Volume: EEMA

The iShares MSCI Emerging Markets Asia ETF is seeing unusually high volume in afternoon trading Tuesday, with over 2.5 million shares traded versus three month average volume of about 92,000. Shares of EEMA were up about 0.3% on the day. Components of that ETF with the highest - 2025-06-10 14:57:32

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 36,181 Shares of Legend Biotech Co. (NASDAQ:LEGN)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 36.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 136,438 shares of the company’s stock after […] - 2025-06-04 05:02:51

Nuveen Asset Management LLC Acquires 5,700 Shares of Legend Biotech Co. (NASDAQ:LEGN)

Nuveen Asset Management LLC grew its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 5.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 110,586 shares of the company’s stock after purchasing an additional 5,700 shares during the period. Nuveen Asset Management LLC’s […] - 2025-06-02 05:04:55

Legend Biotech Co. (NASDAQ:LEGN) Shares Acquired by Squarepoint Ops LLC

Squarepoint Ops LLC grew its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 44.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 127,900 shares of the company’s stock after acquiring an additional 39,197 shares during the quarter. Squarepoint Ops […] - 2025-05-27 05:13:00

Millennium Management LLC Has $8.31 Million Holdings in Legend Biotech Co. (NASDAQ:LEGN)

Millennium Management LLC lessened its stake in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 55.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 255,468 shares of the company’s stock after selling 314,908 shares during the quarter. Millennium Management LLC’s […] - 2025-05-26 04:42:54

Deutsche Bank AG Acquires 14,198 Shares of Legend Biotech Co. (NASDAQ:LEGN)

Deutsche Bank AG lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 11.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 135,067 shares of the company’s stock after acquiring an additional 14,198 shares during the period. Deutsche Bank […] - 2025-05-20 05:12:55

Legend Biotech (NASDAQ:LEGN) Hits New 12-Month Low After Analyst Downgrade

Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) hit a new 52-week low during mid-day trading on Thursday after Truist Financial lowered their price target on the stock from $88.00 to $71.00. Truist Financial currently has a buy rating on the stock. Legend Biotech traded as low as $27.54 and last traded at […] - 2025-05-16 03:02:47

Legend Biotech Co. (NASDAQ:LEGN) Stake Boosted by Stifel Financial Corp

Stifel Financial Corp increased its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 70.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,365 shares of the company’s stock after acquiring an additional 12,955 shares […] - 2025-05-09 05:58:54

Zurcher Kantonalbank Zurich Cantonalbank Trims Position in Legend Biotech Co. (NASDAQ:LEGN)

Zurcher Kantonalbank Zurich Cantonalbank decreased its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 18.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 40,913 shares of the company’s stock after selling 9,355 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Legend […] - 2025-03-19 05:40:51

Morgan Stanley Issues Pessimistic Forecast for Legend Biotech (NASDAQ:LEGN) Stock Price

Legend Biotech (NASDAQ:LEGN – Get Free Report) had its target price dropped by analysts at Morgan Stanley from $82.00 to $80.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s target price points to a potential upside of 111.19% from the company’s current […] - 2025-03-19 04:28:56

Daiwa Securities Group Inc. Raises Stock Position in Legend Biotech Co. (NASDAQ:LEGN)

Daiwa Securities Group Inc. lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 165.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 8,516 shares of the company’s stock after acquiring an additional 5,309 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Legend Biotech were worth $278,000 as […] - 2025-03-17 06:06:55

Company News for Mar 12, 2025

Companies in The News Are: FRG, ORCL, LEGN, PAY - 2025-03-12 11:20:00

Legend Biotech Co. (NASDAQ:LEGN) Receives $79.50 Average PT from Brokerages

Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) have been given a consensus rating of “Buy” by the twelve research firms that are covering the stock, MarketBeat Ratings reports. Twelve analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the stock […] - 2025-03-03 04:50:55

Legend Biotech Co. (NASDAQ:LEGN) Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. lowered its stake in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 2.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 173,766 shares of the company’s stock after selling 3,461 shares during the quarter. Sumitomo Mitsui Trust […] - 2025-02-14 07:35:09

Contrasting Legend Biotech (NASDAQ:LEGN) and COMPASS Pathways (NASDAQ:CMPS)

COMPASS Pathways (NASDAQ:CMPS – Get Free Report) and Legend Biotech (NASDAQ:LEGN – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Earnings & Valuation This table compares COMPASS Pathways […] - 2025-02-06 04:06:58

How The Parts Add Up: KOMP Headed For $62

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-02-04 10:28:33

iShares MSCI EM ESG Enhanced UCITS ETF USD Acc LEGN holdings

Date	Number of LEGN Shares Held	Base Market Value of LEGN Shares	Local Market Value of LEGN Shares	Change in LEGN Shares Held	Change in LEGN Base Value	Current Price per LEGN Share Held	Previous Price per LEGN Share Held
2025-11-11 (Tuesday)	14,573	USD 466,773	USD 466,773
2025-11-10 (Monday)	14,573	USD 460,361	USD 460,361	0	USD -3,060	USD 31.59	USD 31.8
2025-11-07 (Friday)	14,573	USD 463,421	USD 463,421	81	USD -5,685	USD 31.8	USD 32.37
2025-11-06 (Thursday)	14,492	USD 469,106	USD 469,106	0	USD 5,217	USD 32.37	USD 32.01
2025-11-05 (Wednesday)	14,492	USD 463,889	USD 463,889	81	USD 2,016	USD 32.01	USD 32.05
2025-11-04 (Tuesday)	14,411	USD 461,873	USD 461,873	48	USD 390	USD 32.05	USD 32.13
2025-11-03 (Monday)	14,363	USD 461,483	USD 461,483	0	USD -3,878	USD 32.13	USD 32.4
2025-10-31 (Friday)	14,363	USD 465,361	USD 465,361	0	USD 2,154	USD 32.4	USD 32.25
2025-10-30 (Thursday)	14,363	USD 463,207	USD 463,207	54	USD 3,459	USD 32.25	USD 32.13
2025-10-29 (Wednesday)	14,309	USD 459,748	USD 459,748	0	USD -6,296	USD 32.13	USD 32.57
2025-10-28 (Tuesday)	14,309	USD 466,044	USD 466,044	72	USD 8,752	USD 32.57	USD 32.12
2025-10-27 (Monday)	14,237	USD 457,292	USD 457,292	0	USD 3,701	USD 32.12	USD 31.86

Share Trades of LEGN by Blackrock for IE00BHZPJ239

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-07	BUY	81			31.800*		36.42
2025-11-05	BUY	81	32.325	31.610	31.682	USD 2,566	36.46
2025-11-04	BUY	48	32.800	31.580	31.702	USD 1,522	36.48
2025-10-30	BUY	54	32.600	31.600	31.700	USD 1,712	36.54
2025-10-28	BUY	72	32.570	32.585	32.583	USD 2,346	36.58
2025-10-21	BUY	81	32.860	33.085	33.062	USD 2,678	36.69
2025-10-17	BUY	24	31.960	32.270	32.239	USD 774	36.73
2025-09-30	BUY	96	32.610	33.540	33.447	USD 3,211	36.88
2025-09-29	BUY	27	32.850	33.600	33.525	USD 905	36.90
2025-09-25	BUY	108	32.820	32.875	32.869	USD 3,550	36.94
2025-09-18	BUY	108	35.160	35.400	35.376	USD 3,821	36.95
2025-07-02	BUY	135	35.910	36.770	36.684	USD 4,952	36.86
2025-06-26	BUY	27	33.480	33.620	33.606	USD 907	36.90
2025-06-25	BUY	351	33.430	33.980	33.925	USD 11,908	36.92
2025-06-13	BUY	108	36.830	37.185	37.150	USD 4,012	37.01
2025-06-11	BUY	108	36.590	37.900	37.769	USD 4,079	37.00
2025-06-02	BUY	162	29.320	29.790	29.743	USD 4,818	37.23
2025-05-30	BUY	27	28.950	29.070	29.058	USD 785	37.29
2025-05-09	BUY	54	31.780	32.970	32.851	USD 1,774	38.24
2025-05-08	BUY	54	32.040	32.130	32.121	USD 1,735	38.29
2025-04-29	BUY	324	34.430	35.240	35.159	USD 11,392	38.59
2025-03-21	SELL	-297	36.950	37.370	37.328	USD -11,086	40.05 Profit of 807 on sale
2025-03-20	BUY	54	37.720	38.000	37.972	USD 2,050	40.07
2025-03-19	BUY	54	38.080	38.160	38.152	USD 2,060	40.09
2025-02-13	SELL	-81	36.390	37.110	37.038	USD -3,000	41.36 Profit of 350 on sale
2025-02-06	SELL	-162	36.110	38.970	38.684	USD -6,267	41.84 Profit of 511 on sale
2025-02-03	SELL	-189	37.310	38.320	38.219	USD -7,223	42.05 Profit of 725 on sale
2024-10-21	BUY	54	43.450	44.480	44.377	USD 2,396	0.00
2024-10-21	BUY	54	43.450	44.480	44.377	USD 2,396	0.00

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LEGN

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer